Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases

NCT03370601 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Not enough recruitment Lack of funding CR

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: Infliximab
DRUG: Mercaptopurine
DRUG: Azathioprine
DRUG: Infliximab

Sponsor

University Hospital, Lille